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Abstract
Background: Scintillation camera imaging is used for treatment planning and post-treatment dosimetry in liver
radioembolization (RE). In yttrium-90 (90Y) RE, scintigraphic images of technetium-99m (99mTc) are used for treatment
planning, while 90Y Bremsstrahlung images are used for post-treatment dosimetry. In holmium-166 (166Ho) RE,
scintigraphic images of 166Ho can be used for both treatment planning and post-treatment dosimetry. The aim of this
study is to quantitatively evaluate and compare the imaging characteristics of these three isotopes, in order that imaging
protocols can be optimized and RE studies with varying isotopes can be compared.
Methodology/Principal Findings: Phantom experiments were performed in line with NEMA guidelines to assess the spatial
resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y and 166Ho. In addition, Monte Carlo
simulations were performed to obtain detailed information about the history of detected photons. The results showed that
the use of a broad energy window and the high-energy collimator gave optimal combination of sensitivity, spatial
resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the medium-energy
collimator were small. For 166Ho, the high-energy collimator also slightly outperformed the medium-energy collimator. In
comparison with 99mTc, the image quality of both 90Y and 166Ho is degraded by a lower spatial resolution, a lower
sensitivity, and larger scatter and collimator penetration fractions.
Conclusions/Significance: The quantitative evaluation of the scintillation camera characteristics presented in this study
helps to optimize acquisition parameters and supports future analysis of clinical comparisons between RE studies.
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Introduction
Intra-arterial liver radioembolization (RE) using microspheres
loaded with a high-energy beta emitting isotope, is an emerging
technique for radiation treatment of patients with unresectable
liver tumors [1,2]. RE leads to high tumor absorbed radiation
doses, while the surrounding healthy liver tissue is spared [3]. RE
is generally a two-step procedure, consisting of i) the administra-
tion of a small amount of activity, the scout dose, and ii)
subsequent administration of the activity that is expected to have a
therapeutic effect, the therapy dose. The spatial distribution of the
scout dose is expected to represent the distribution of the therapy
dose, and can consequently be used to predict safety of the
procedure.
The spatial distribution of the scout and therapy dose is
commonly assessed using scintillation camera imaging. Following
administration of the scout dose, the patient undergoes single
photon emission computed tomography (SPECT) to detect
extrahepatic deposition of activity, which is a contra-indication
for therapy, and planar scintillation camera imaging to determine
the percentage of activity that shunted to the lungs. A high lung-
shunting (LS) percentage provokes reduction of the therapy dose
(10%,LS,20% (SIR-Spheres package insert; Sirtex Medical,
Sydney, Australia)) or even cancellation of therapy (LS.20%).
After treatment, a SPECT scan of the therapy dose is usually
acquired to confirm absence of extrahepatic activity. This scan can
also be used to retrospectively assess a dose-response relation.
The beta-emitter yttrium-90 (
90Y, Table 1) is most frequently
used for RE. Its distribution can be assessed by means of SPECT
imaging of the Bremsstrahlung photons [4–7]. Unfortunately, the
continuous Bremsstrahlung energy spectrum comprises photon
energies ranging up to 2 MeV, and is therefore associated with
poor image quality [7]. For this reason, Technetium-99m-labeled
macroaggregated albumin particles (
99mTc-MAA) are generally
used for the scout dose, as a substitute for the
90Y microspheres,
since the image quality is much better [8,9]. The
99mTc-MAA
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the
90Y microspheres, potentially affecting the spatial distribution
of the scout dose [10,11]. Furthermore, the instability of
99mTc-
MAA particles frequently leads to uptake of dissociated
99mTc-
pertechnetate in the thyroid and gastrointestinal tract [12], and to
shunting of smaller and disintegrated particles to the lungs [13],
which altogether may cause false adjustment of the
90Y therapy
dose. As a potential alternative to
90Y microspheres, holmium-166
(
166Ho, Table 1) loaded microspheres are currently investigated in
a clinical study [14–18]. The higher specific activity and shorter
half life may have a beneficial impact on tumor kill. Additionally,
the imaging characteristics of
166Ho are believed to be more
suitable for quantitative imaging than
90Y, because it is a
combined beta-gamma emitter [19,20].
166Ho microspheres may
conceivably be used for both the scout dose and the therapy dose,
which potentially improves the predictive value of the scout dose
distribution and post-therapy liver dosimetry.
Scintillation camera images of
99mTc,
90Y, and
166Ho are all
used for clinical assessment of the activity distribution in liver RE,
but they have differing imaging characteristics. In contrast to
99mTc, information on the scintillation camera imaging charac-
teristics of
90Y and
166Ho is sparse, and a systematical comparison
between these three isotopes does not exist. Therefore, the aim of
this study is to provide a systematical evaluation and comparison
of the scintillation camera imaging characteristics of
90Y,
166Ho
and
99mTc, using a series of phantom experiments and Monte
Carlo simulations. This is important for (future) clinical compar-
isons between microsphere RE studies with varying isotopes and
imaging protocols. In addition, the outcome of this study can be
used to optimize the acquisition settings for
90Y and
166Ho
imaging, and to guide future developments in SPECT image
reconstruction.
Materials and Methods
The spatial resolution, sensitivity, count rate linearity, and
contrast recovery of
99mTc,
90Y, and
166Ho were evaluated by
means of phantom experiments. If possible, the well-defined
National Electrical Manufacturers Association (NEMA) 2007
guidelines were adopted, facilitating (future) comparison with
other isotopes and acquisition protocols [21,22]. In addition,
Monte Carlo simulations were performed to yield data that cannot
be retrieved from physical experiments, including the fractions of
primary photons, scattered photons, and collimator-penetrated
photons of the line source measurements.
Phantom experiments
Data was acquired with a Philips FORTE
TM dual-headed
camera with 3/8 inch thick thallium-doped sodium-iodide
(NaI(Tl)) crystals.
99mTc measurements were performed with the
low-energy general purpose (VXGP) collimator. Medium-energy
(MEGP) and high-energy general purpose (HEGP) collimators
were mounted for the
90Y and
166Ho measurements, to reduce
collimator penetration of high-energy photons. The energy
window settings for
90Y Bremsstrahlung imaging vary between
institutions, ranging from small windows with a relatively low
central energy [23,24], to intermediate [5,6] and broad energy
windows [4,7,25–27]. Although it is generally believed that a wide
energy window is required to maintain sufficient sensitivity, no
consensus exists on the optimal central energy and window width.
Therefore, both a broad 50–250 keV window, which optimizes
sensitivity, and a smaller 120–250 keV window, which is expected
to have less scatter contamination, were evaluated in this study.
The used energy window settings and collimator characteristics
are listed in Table 1 and 2, respectively.
Spatial resolution. Spatial resolution defines whether small
accumulations of activity, e.g. in or around tumors, can be
detected and quantified. Projection images (matrix=2566256,
pixelsize=2.33262.332 mm
2) of a 28 cm long line source with an
inner diameter of 2 mm were acquired. To create realistic conditions
with regard to electron absorption, and (Bremsstrahlung) photon
emission and scatter, the line source was centered in 2, 10, and
20 cm of poly(methyl methacrylate) (PMMA), leading to 1, 5, and
10 cm of scatter material below and on top of the source.
Measurements were performed with a source to collimator
distance of 2, 6 and 11 cm for 1 cm of scatter material and 11 cm
for the measurements with 5 and 10 cm of scatter material
(Figure 1). The central lines perpendicular to the source were
summed over a distance of 10 cm to obtain the line spread
function (LSF). The full width at half maximum (FWHM) and the
Table 1. Radioisotope characteristics and measurement settings.
Isotope Half-life [h] Ebmax [MeV]
a Ec [keV]
b Ewin [keV]
c Collimator
99mTc 6.0 N/A 140.5 (89%) 130–151 VXGP
90Y 64.1 2.28 (99.9%) Bremsstrahlung 120–250 MEGP
50–250 HEGP
166Ho 26.8 1.77 (48.7%) 80.6 (6.7%) 74.6–86.6 MEGP
1.85 (50.0%) 1379.4 (0.9%) HEGP
1581.0 (0.2%)
aEbmax represents the maximum energy and abundance of the beta particles.
bEc represents the gamma photon energy and abundance.
cEwin represents the lower and upper limits of the energy window.
doi:10.1371/journal.pone.0026174.t001
Table 2. Collimator characteristics.
Collimator
Hole size
(mm)
Septal thickness
(mm)
Length
(mm)
VXGP 1.78 0.152 42
MEGP 2.95 1.143 48
HEGP 3.81 1.727 60
All collimators have hexagonal hole shapes.
doi:10.1371/journal.pone.0026174.t002
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determined according to NEMA guidelines.
Sensitivity. The imaging sensitivity of an isotope is directly
related to the image noise, which can be important for detection of
small amounts of extrahepatic activity. As described by NEMA, a
Petri dish was filled with a thin layer of activity, which was
beforehand measured with a calibrated dose calibrator. The dish
was placed in the center of the field-of-view of the camera, at a
distance of 10 cm and 40 cm from the collimator. To ensure
stopping all electrons and proper creation of the Bremsstrahlung
photons, 1 cm thick PMMA slabs were placed below and on top of
the dish for the
90Y and
166Ho sensitivity measurements. In each
measurement, 4 million counts were acquired. The sensitivity (S)
[cps Mbq
21] was calculated as the total number of counts in the
field-of-view, divided by acquisition time times activity.
To enable calculation of the system count-rate linearity,
described in the next section, the sensitivity measurements were
simultaneously acquired in two energy windows: the regular
photopeak energy window, and an energy window covering the
complete energy range of the camera (‘full-energy-window’).
Count rate linearity. In RE, therapy doses up to several
GBqs are typically administered to the patient. These high
activities can lead to detector dead-time and, consequently, to
underestimation of the dose. This effect is described by the system
count rate curve, that depends on i) the system sensitivity, which is
determined by the number of photons that pass the collimator and
fall within the energy window, and ii) the dead-time, which
depends on the total number of photons that hit the crystal. The
first can be measured as described in the ‘sensitivity’ section. The
latter is theoretically described by Sorensen’s count rate model for
paralyzable scintillation cameras [28] and can be provided by the
intrinsic count rate measurements described here.
Cylindrical vials with an inner diameter of 2.4 cm were filled
with the isotopes solved in 11 ml water. Activities ranged from
0.5–24.5 MBq for
99mTc, 16.9–350.8 MBq for
90Y and 5.0–
121.1 MBq for
166Ho, to include count rates from the linear range
to count rates that cause dead-time effects. The vials were placed
in the center of the field-of-view of the camera, at 66.5 cm from
the detector, resulting in a uniform photon flux on the detector.
The acquisition time was 10 minutes and the energy window was
set to the full-energy-window, yielding an intrinsic count rate [cps]
comprised of all photons that hit the detector.
From the intrinsic count rate curve (measured in the full-energy-
window), the system sensitivity in the full-energy-window, and the
system sensitivity in the photopeak window, the system count rate
in the photopeak window can be calculated for each isotope and
collimator and plotted as a function of activity. The reported
maximum activity with linear count rate response (Alinmax) was
defined as the highest activity with less than 2% loss of count rate.
The corresponding maximum achievable linear count rate
(Rlinmax) was also reported.
Contrast recovery. Contrast recovery is important if
quantification of local accumulation of activity is required, as is
the case with image based tumor dosimetry in RE. Contrast
recovery was determined using a fillable torso-shaped NEMA
image quality phantom (volume=9700 ml) containing six fillable
coplanar spheres (inner diameter=10, 13, 17, 22, 28, and
37 mm). Lung tissue was simulated by a central cylindrical lung
insert. The phantom background activity concentrations and
SPECT scan times were matched to obtain the total number
of counts corresponding to a 30 minutes SPECT scan with
clinically realistic liver activity concentrations: 137 kBq ml
21,
573 kBq ml
21, and 166 kBq ml
21, for
99mTc,
90Y, and
166Ho,
respectively, and a sphere-to-background activity concentration
ratio (R) of 9:1. These activity concentrations were based on a
scout dose for
99mTc and
166Ho, and a therapy dose for
90Y.
SPECT data was acquired in 120 projections over a 360u orbit.
Volumes were reconstructed using filtered back-projection (FBP),
on a 12861286128 grid with an isotropic voxel size of 4.664 mm.
No additional filtering other than the ramp filter was applied. Post-
reconstruction, images were corrected for attenuation using the
Chang algorithm with a non-uniform effective broad beam linear
attenuation coefficient. Contrast recovery coefficients (QH) were
calculated in accordance with NEMA guidelines. An example of
the filled phantom with hot sphere and background regions of
interest (ROI) is given in Figure 2.
Monte Carlo simulations
Monte Carlo simulations were performed with the well
validated general purpose Monte Carlo radiation transport code
mcnpx 2.5.0 [29]. The camera head was modeled realistically
including collimator housing, collimator, aluminum crystal
housing, NaI(Tl) crystal, 5 cm of crown glass mimicking the
backscatter compartments, and lead shielding. Both gamma
Figure 1. Schematic overview of the spatial resolution
measurement of the line-source centered in 20 cm PMMA.
Shown are the camera, including the collimator (A), a stack of 20 PMMA
slabs of size 4064061 cm (B), the location of the line-source (C), and
the patient bed (D). The line-source to collimator-face distance is 11 cm.
doi:10.1371/journal.pone.0026174.g001
Figure 2. Overview of the hot sphere and background ROI. The
slice through the center of the spheres of the contrast recovery
phantom filled with
99mTc is shown. Overlaid are the locations of the
lung insert (central red ROI), the hot sphere ROI (peripheral red ROI),
and 11 of the 55 background ROI of the largest sphere (green ROI).
doi:10.1371/journal.pone.0026174.g002
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99mTc and
166Ho) and Bremsstrahlung photon (for
90Y
and
166Ho) contributions were simulated. The mono-energetic
gamma photons were simulated weighted by their relative
abundance as given in Table 1. Only 2.0% of the
90Y and 1.2%
of the
166Ho beta emissions lead to Bremsstrahlung photons with
an energy higher than 50 keV. Therefore, the Bremsstrahlung
photons were sampled from a predefined energy spectrum and
source distribution, similar to the approach published by Rault
et al [30], which improved the efficiency of the simulations
substantially.
Primary, scatter, and penetration fraction. Monte Carlo
simulations were performed to estimate the fractions of primary
(PF), scattered (SF) and collimator-penetrated (CPF) photons.
Since high SF and CPF have deteriorating effects on the image
quality, their characterizations give insight into the effectiveness of
the chosen collimator and energy window. The geometry of the
simulations was equal to the geometry of measurements of the line
source centered in 20 cm PMMA, shown in Figure 1. A detected
photon was defined as a photon that deposited at least part of its
energy in the crystal, sub-divided in three groups:
i) Primary photons: detected photons that did not interact with
material or penetrate through the collimator.
ii) Scattered photons: detected photons that scattered in the
PMMA, photons that scattered in the camera-housing or
detector, and photons that were created in the collimator
(lead x-rays). None of these photons penetrated the
collimator.
iii) Penetrated photons: all detected photons (unscattered or
scattered) that penetrated through the collimator.
The number of photons released was 300 million for both
gamma photon and Bremsstrahlung photon simulations. Equal to
the spatial resolution measurements, the central lines perpendic-
ular to the source were summed over a distance of 10 cm to obtain
the LSF. The total
166Ho LSF was calculated as the abundance
weighted summation of gamma and Bremsstrahlung photon
contributions. The experimental and simulated LSF measure-
ments were compared visually.
Results
Phantom experiments
Spatial resolution. Table 3 lists the FWHM and FWTM in
mm of the measured LSF for the three isotopes. In both energy
windows, the
90Y LSF showed smaller FWHM and FWTM for the
HEGP than for the MEGP collimator. The FWHM were slightly
smaller for the 120–250 keV window than for the 50–250 keV
window, but the FWTM were substantially larger. For
166Ho, the
HEGP collimator yielded a higher resolution than the MEGP
collimator, as can be appreciated by the slightly smaller FWHM,
and substantially smaller FWTM, for all measurements.
Sensitivity. The planar sensitivities, measured at a distance of
10 and 40 cm from the collimator face, are listed in Table 4. As
was expected from the photon abundances, the
99mTc sensitivity
was higher than the
166Ho sensitivity. The
90Y sensitivity was
lower than
166Ho sensitivity for both energy windows. No
difference was observed between the
99mTc sensitivities at 10 cm
and 40 cm, indicating proper collimation of the photons. To the
contrary, the sensitivity for both
90Y and
166Ho decreased at a
larger distance from the collimator, due to collimator penetration
effects. This effect was larger for the MEGP collimator than for the
HEGP collimator.
Count rate linearity. Figure 3A shows the observed intrinsic
count rate as a function of the ideal count rate for all isotopes. As
expected, this intrinsic count rate curve did not depend on the
isotope imaged and was fitted well by Sorensen’s count rate model
of paralyzable scintillation cameras [28]. Figure 3B shows the
system count rate curves for all isotopes and measurement settings,
estimated from the intrinsic count rate curve and the system
sensitivities. Alinmax and Rlinmax are listed in Table 5. The Alinmax
of approximately 1.5 GBq for
166Ho might be a limitation for
scintillation camera imaging directly after treatment. The
quantitative accuracy of imaging the
99mTc-MAA scout dose
(,150 MBq),
166Ho scout dose (,250 MBq), and
90Y therapy
dose (,1–3 GBq) in the clinical range will not be affected by dead-
time effects.
Contrast recovery. Figure 4 shows the slice through the
centers of the spheres of all FBP reconstructed images. In Figure 5,
contrast recovery coefficients are shown as a function of sphere
diameter. The
99mTc contrast recovery was 59% for the largest
sphere. For
90Y and
166Ho, this was 17% and 35%, respectively.
Neither collimator choice, nor energy window choice affected the
90Y contrast recovery much. Also, no difference was observed
between the MEGP and HEGP
166Ho contrast recovery curves.
Monte Carlo simulations
Primary, scatter, and penetration fraction. The
measured and simulated LSF of the line source centered in
20 cm PMMA are shown in Figure 6. The good agreement
between both the center and the tails confirms the accuracy of the
Monte Carlo simulations. The simulated LSF were subdivided in
the three different photon classification groups. Table 6 lists the
PF, SF and CPF of each isotope. For both
90Y and
166Ho, the
HEGP collimator yielded a higher PF than the MEGP collimator,
due to reduction of the number of penetrated photons. PF was
Table 3. Spatial resolution given as the FWHM (FWTM) in mm.
99mTc
90Y 120–250 keV
90Y 50–250 keV
166Ho
VXGP MEGP HEGP MEGP HEGP MEGP HEGP
S01D02 5.4 (10.4) 11.5 (173.7) 7.0 (113.1) 10.9 (123.2) 7.5 (49.2) 11.1 (61.7) 6.5 (17.2)
S01D06 6.6 (12.3) 12.9 (222.2) 11.0 (137.2) 11.4 (149.7) 11.1 (60.2) 11.7 (42.2) 10.5 (21.5)
S01D11 8.2 (15.0) 17.1 (286.1) 15.3 (160.0) 15.8 (172.9) 15.4 (57.6) 14.7 (35.8) 14.1 (25.4)
S05D11 8.4 (16.6) 19.7 (300.6) 16.4 (218.9) 19.4 (235.7) 17.0 (159.3) 15.8 (97.0) 14.6 (43.5)
S10D11 8.5 (17.4) 28.1 (341.2) 18.1 (269.5) 26.3 (294.9) 20.1 (241.3) 15.6 (168.3) 14.9 (113.7)
S01D02 corresponds to the measurement with 1 cm of scatter material and line-source to collimator distance of 2 cm, S01D06 to the measurement with 1 cm of scatter
material and line-source to collimator distance of 6 cm, etc.
doi:10.1371/journal.pone.0026174.t003
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90Y measured in the 120–250 keV window and in the
50–250 keV energy window, but the first was more contaminated
by septal penetration, and the latter more by scatter. The
166Ho
LSF was more contaminated by septal penetration than by scatter.
Discussion
The scintillation camera imaging characteristics of three
isotopes used in RE were quantitatively evaluated with phantom
experiments and Monte Carlo simulations. Although the superi-
ority of
99mTc was expected, its characteristics are valuable in
evaluation of and comparison to the other two isotopes.
NEMA prescribes assessment of spatial resolution by means of
point source measurements, but the more practical approach of
the line source was chosen in this work. Nonetheless, good
agreement between the FWHM presented here and in the
literature was found for all isotopes. The measured FWHM of
99mTc appeared to be slightly larger than that given in the
specifications of the camera manufacturer (8.2 mm and 7.8 mm,
respectively). This difference might be due to the measurement set-
up with the source behind 1 cm PMMA. Indeed, measurement of
the
99mTc line source in air (data not shown) yielded a FWHM of
7.7 mm. The set-up was chosen, however, to be in line with
90Y
and
166Ho measurements, which need the scatter material around
the source to create all Bremsstrahlung photons. The spatial
resolution of the
90Y LSF was in good agreement with results of
previous studies, despite small differences in measurement settings.
Shen et al reported a FWHM of 12.5 mm for a point source
placed behind 1.8 cm of lucite, a source to detector (HEGP
collimator) distance of 6.8 cm and an energy window of 55–
285 keV [7], which is in good agreement with the FWHM of
11.4 mm found in this study for the line source behind 1 cm
PMMA, a source to detector distance of 6 cm, and an energy
window of 50–250 keV. Interestingly, the FWHM of the 120–
250 keV window was slightly smaller than the 50–250 keV
window, whereas the FWTM was substantially larger. This effect
can be explained by the higher (collimator) scatter fraction in the
50–250 keV window, which broadened the FWHM, and the
larger amount of collimator penetration in the 120–250 window,
which caused a large FWTM. The spatial resolution of
166Ho was
Table 4. Sensitivity in counts per second per unit activity.
99mTc
90Y 120–250 keV
90Y 50–250 keV
166Ho
VXGP MEGP HEGP MEGP HEGP MEGP HEGP
S - 10 cm [cps MBq
21] 63.8 6.0 3.1 10.5 6.0 12.6 10.6
S - 40 cm [cps MBq
21] 63.1 3.0 1.8 6.0 4.9 9.9 8.2
doi:10.1371/journal.pone.0026174.t004
Figure 3. Intrinsic and system count rate linearity curves. (A) The observed count rate is plotted as a function of ideal count rate. Sorensen’s
count rate model for paralyzable cameras (solid line) is fitted to the intrinsic count rate measurements (data points). The ideal camera count rate
response, without dead-time effects, is plotted by the dashed line. (B) Shown are the system count rate curves (solid lines), composed of the intrinsic
count rate linearity curve and the system sensitivity measurements. The slope of the ideal system camera count rate response (dashed lines)
corresponds to the system sensitivity.
doi:10.1371/journal.pone.0026174.g003
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approximately 16 mm of a line source measured behind 12 cm of
scatter material [19], which is in good agreement with the FWHM
of 15.6 mm of the
166Ho line source behind 10 cm PMMA
(HEGP, collimator distance 11 cm) found in this study.
The
90Y planar system sensitivity was similar to earlier reports
[7]. The sensitivity found for
166Ho was higher than the window-
based, non-primary subtraction corrected sensitivity reported by
Bayouth and Macey [19]. Good agreement was found if taking
into account that about half of the detected photons of this study
are non-primary, as was estimated from Monte Carlo simulations.
The MEGP collimator showed a higher planar sensitivity than the
HEGP collimator for both
90Y and
166Ho. However, Monte Carlo
simulations elucidated higher primary fractions for the HEGP
than for the MEGP collimator (Table 6). Monte Carlo simulations
also revealed that
90Y and
166Ho non-primary photons lack spatial
information, as is illustrated in Figure 6. Taking this into account,
the useable sensitivity of the HEGP collimator, i.e. the sensitivity
for primary photons, is similar to that of the MEGP collimator.
With similar number of primary photons, and less background
signal due to penetrated photons, the HEGP is preferred over the
MEGP collimator for both
90Y and
166Ho.
The contrast recovery SPECT data was reconstructed using
FBP, without inclusion of collimator modeling and scatter
correction techniques. Compared to (model-based) iterative
reconstruction algorithms, the FBP approach will result in
suboptimal contrast recovery, but the first requires parameters
that need to be optimized and have a large effect on image quality,
such as the number of iterations. Reasonably accurate model-
based quantitative image reconstruction methods have been
proposed for both
166Ho and
90Y [5,20], but these have distinct
underlying algorithms, which makes straight-forward comparison
of the isotope performance difficult. The FBP reconstructed
contrast recovery coefficients reported in this study should not be
interpreted as a measure of maximum isotope performance, but as
a measure of isotope performance relative to each other. Since
contrast recovery depends on resolution, scatter and penetration, it
can be interpreted as a quantitative measure of overall image
quality. This image quality of
99mTc is higher than the
166Ho
image quality, which in turn is higher than that of
90Y (Figure 5).
No differences in
90Y contrast recovery were observed between
energy windows and collimators. Although the HEGP collimator
demonstrated a higher spatial resolutions and higher primary
photon fraction than the MEGP collimator, differences were
potentially too subtle to cause a substantial gain in contrast
recovery in the FBP reconstructed images. Likewise, the
166Ho
contrast recovery curves did not show differences between the
MEGP and HEGP collimators. From Figure 4, however, it can be
appreciated that the perceptual
90Y image quality is substantially
better in the 50–250 keV energy window than the 120–250 keV
energy window, due to reduction of the image noise. It can
therefore be postulated that the use of a broad energy window and
a HEGP collimator gave the optimal combination of sensitivity,
spatial resolution and primary photon fraction for
90Y imaging,
although differences with the MEGP collimator were small. The
HEGP collimator also slightly outperformed the MEGP collimator
in the
166Ho experiments.
The Monte Carlo simulations provided valuable information on
the contribution and spatial distribution of different classes of
photons, which could not be obtained by performing measure-
ments alone. As is illustrated in Figure 6, there is a fundamental
difference between the penetrated photons of
99mTc and those of
Table 5. Estimated maximum activity in the linear detection
range and corresponding estimated maximum linear count
rate.
99mTc
90Y 120–
250 keV
90Y 50–
250 keV
166Ho
VXGP MEGP HEGP MEGP HEGP MEGP HEGP
Alinmax
[MBq]
1095 7595 14430 7595 14430 1420 1891
Rlinmax
[kcps]
68 45 44 78 85 18 20
doi:10.1371/journal.pone.0026174.t005
Figure 4. FBP reconstructed images of the contrast recovery phantom. The slices through the center of the spheres of the contrast recovery
phantom are shown for
99mTc and VXGP (A),
90Y 120–250 keV and MEGP (B),
90Y 120–250 keV and HEGP (C),
90Y 50–250 keV and MEGP (D),
90Y 50–
250 keV and HEGP (E),
166Ho and MEGP (F), and
166Ho and HEGP (G). All images were linearly window-leveled from 0 to 4 times the average
background intensity.
doi:10.1371/journal.pone.0026174.g004
Figure 5. Contrast recovery as a function of sphere diameter.
QH is the recovery of sphere-to-background contrast in the measure-
ment, as compared to the true contrast in the phantom.
doi:10.1371/journal.pone.0026174.g005
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166Ho. Collimator penetration of
99mTc photons is
dominated by photons that slightly graze the septum edge. These
photons maintain their spatial information. On the contrary,
collimator penetration of
90Y and
166Ho is dominated by high-
energy photons that, after penetration, scatter in the crystal or
backscatter in the camera. These photons lack spatial information
and degrade the image quality. Also, from Figure 6 it can be
appreciated that photon scatter is the main source of degradation
of
90Y image quality in the 50–250 keV energy window, and
collimator penetration in the 120–250 keV energy window.
The results presented in this paper suggest that accurate scatter
and collimator penetration correction techniques could greatly
enhance the quantitative accuracy of
90Y and
166Ho scintillation
camera imaging. Quantitative accuracies of
99mTc SPECT with
optimized correction techniques are typically within 5% for
phantom studies and within 10% for clinical studies [31–34].
Figure 6. Measured and simulated LSF of the line-source centered in 20 cm PMMA. (A) LSF of the
99mTc line-source and VXGP collimator,
(B)
166Ho and HEGP, (C)
90Y 120–250 keV and HEGP, and (D)
90Y 50–250 keV and MEGP. Data is plotted on semi-logarithmic scale, showing good
agreement between the measurements (data points) and simulations (blue solid line). The intensity is normalized to the total number of counts in the
ROI. Contributions of primary, scattered, and penetrated photons are shown in green, light blue, and red, respectively.
doi:10.1371/journal.pone.0026174.g006
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already been reported for
166Ho SPECT by de Wit et al. [20] and
for
90Y by Minarik et al. [5]. The quantitative accuracy of
99mTc
SPECT might be approached if these correction schemes are
further improved, which is important for accurate assessment of
the distribution of the scout dose, determination of the lung-
shunting fraction, and post-therapy liver dosimetry in radio-
embolization.
Besides scintillation camera imaging, other imaging modalities
may also allow for quantitative assessment of the microsphere
distribution in radioembolization. Recently, Positron Emission
Tomography (PET) was proposed to image the
90Y therapy dose
distribution [35–38] and phantom experiments have demonstrated
the feasibility of quantitative imaging of the distribution of (non-
radioactive) holmium with magnetic resonance imaging (MRI)
[15,39,40]. Although both
90Y PET and holmium MRI have
intrinsically promising imaging characteristics, such as a high
spatial resolution, the clinical value of these modalities in
microsphere radioembolization is yet unknown and subject of
ongoing research.
In this study, the scintillation camera imaging characteristics of
three isotopes used in radioembolization were quantitatively
evaluated and compared. The use of a broad energy window
and HEGP collimator gave optimal combination of sensitivity,
spatial resolution, and primary photon fraction for
90Y Brems-
strahlung imaging, although differences with the MEGP collima-
tor were small. For
166Ho imaging, the HEGP collimator slightly
outperformed the MEGP. The image quality of both
90Y and
166Ho was affected more by partial volume effects, scatter, and
collimator penetration than that of
99mTc. The detailed break-
down of these imaging characteristics can help to direct the
optimization of acquisition protocols and quantitative reconstruc-
tion algorithms for
90Y and
166Ho SPECT. The characterization
of the three isotopes can guide future comparisons between or
within clinical radioembolization studies with varying isotopes and
imaging protocols.
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